BayBio presents an afternoon forum for life science industry insiders. From the event description:
“Large pharmaceutical companies often tap biotech for novel technologies to replenish the product pipeline. Enter the financial crisis of 2009. Restless investors, dormant equity markets, and limited exit opportunities amplified the risk life science innovation faces in the lab.
As the Valley of Death widens, our industry is faced with key questions:
A panel of key industry stakeholders will discuss challenges facing the industry and offer their outlook on the future. They will engage in a thoughtful dialogue with the audience to generate practical and actionable ideas for navigating the Valley of Death.”
Information and registration here.